Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Minoxidil can cause dangerous fluid buildup around the heart.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Low iron levels are linked to more hair loss in non-menopausal women.

Acceptance reduces hair loss distress and medical consultations; coping mechanisms increase them.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.

Bald men may have a lower risk of testicular cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Iron deficiency is linked to hair loss in adolescents, especially females, in northern Sudan.

Older age, family history, and low iron levels increase the risk of female hair loss.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

People who are more materialistic often expect life changes from buying things, leading to more debt and credit misuse.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.